Hayakawa Building
Edmund Halley Road The Oxford Science Park
Oxford OX4 4GB
United Kingdom
44 18 6540 5560
https://investors.niox.com
Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees:
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Ian Roy Johnson | Executive Chairman | 698.31k | N/A | 1953 |
Mr. Michael Roy David Roller A.C.A., BA (Hons) | CFO & Director | 526.57k | N/A | 1965 |
Mr. Jonathan Emms | COO & Executive Director | 694.52k | N/A | 1963 |
Ms. Nina Kataria | Senior Vice President Global Human Resources | N/A | N/A | N/A |
Mr. Tom Scaccia | Senior Vice President of Americas & Research Business | N/A | N/A | N/A |
Ms. Sarah Elizabeth Duncan | Company Secretary | N/A | N/A | N/A |
NIOX Group Plc, a diagnostics and management company, design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.
NIOX Group Plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.